<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: EVT.F News</title><copyright>Copyright (c) 2010 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=evt.f</link><description>Latest Financial News for EVOTEC</description><language>en-us</language><lastBuildDate>Mon, 14 Dec 2009 07:05:20 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Evotec Achieves Milestone in Medicinal Chemistry Collaboration With Ono Pharmaceutical Co., Ltd. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091214/180224.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1537999178</guid><pubDate>Mon, 14 Dec 2009 07:05:20 Etc/GMT</pubDate></item><item><title>Evotec Wins German Government Research Grant (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091118/178680.html?.v=1</link><description>HAMBURG, Germany -- Evotec , a leading provider in the discovery and development of novel small molecule drugs, today announced that it has been granted up to EUR 2.5 m in research funds from the BMBF, within the Neu2 consortium, to advance research and development activities on the target Serine Racemase for potential use in neuroprotection.</description><guid isPermaLink="false">yahoo_finance/3941151402</guid><pubDate>Wed, 18 Nov 2009 07:05:32 Etc/GMT</pubDate></item><item><title>Q3 2009 Evotec AG Earnings Release - Time Not Supplied (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091112.html?t=evt.f</link><description></description><guid isPermaLink="false">yahoo_finance/3060977403</guid><pubDate>Thu, 12 Nov 2009 12:07:24 Etc/GMT</pubDate></item><item><title>Evotec Third Quarter Financial Results: Growth of Business and Restructuring Impact Lead the Path to Sustainability (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178256.html?.v=1</link><description>HAMBURG, Germany -- Evotec AG today reported results and corporate updates for the third quarter and nine months ended September 30, 2009.</description><guid isPermaLink="false">yahoo_finance/2426467925</guid><pubDate>Thu, 12 Nov 2009 07:36:29 Etc/GMT</pubDate></item><item><title>Evotec to Voluntarily Delist From NASDAQ (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091110/178023.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1058540233</guid><pubDate>Tue, 10 Nov 2009 07:06:25 Etc/GMT</pubDate></item><item><title>Evotec and Boehringer Ingelheim Extend and Broaden Research Collaboration (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091109/177891.html?.v=1</link><description>HAMBURG, Germany -- Evotec AG today announced that it has extended the research collaboration with Boehringer Ingelheim for a further 4 years. The collaboration was initiated in August 2004 and has been extended on two previous occasions.</description><guid isPermaLink="false">yahoo_finance/2609433297</guid><pubDate>Mon, 9 Nov 2009 09:23:32 Etc/GMT</pubDate></item><item><title>Evotec to Report Third Quarter 2009 Results on 12 November 2009 (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091106/177791.html?.v=2</link><description>HAMBURG, Germany -- Evotec AG will report its financial results for the third quarter of 2009 on Thursday, 12 November 2009.</description><guid isPermaLink="false">yahoo_finance/946508248</guid><pubDate>Fri, 6 Nov 2009 11:33:29 Etc/GMT</pubDate></item><item><title>Evotec Receives a EUR 2.5 Million Milestone Payment in Its Research Collaboration With Boehringer Ingelheim (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091022/176210.html?.v=1</link><description>HAMBURG, Germany -- Evotec AG today announced that it has achieved another milestone in its research collaboration with Boehringer Ingelheim. The collaboration, which was initiated in August 2004, has up to now resulted in seven milestone payments.</description><guid isPermaLink="false">yahoo_finance/3536899521</guid><pubDate>Thu, 22 Oct 2009 06:05:00 Etc/GMT</pubDate></item><item><title>Evotec Extends Medicinal Chemistry Collaboration With Ono Pharmaceutical Co., Ltd. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091015/175564.html?.v=1</link><description>HAMBURG, Germany -- Evotec AG today announced that it has extended its current research collaboration with Ono Pharmaceutical Co., Ltd. and initiated a new discovery collaboration. Under the contract extension Evotec will provide integrated drug discovery activities, including high throughput screening, medicinal chemistry and in vitro pharmacology to discover novel, small molecular weight compounds active against an ion channel target selected by Ono.</description><guid isPermaLink="false">yahoo_finance/3418482136</guid><pubDate>Thu, 15 Oct 2009 06:33:00 Etc/GMT</pubDate></item><item><title>Evotec Achieves Milestone With Cardioxyl Pharmaceuticals - as Compound Enters the Clinic (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091001/174493.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/3472437698</guid><pubDate>Thu, 1 Oct 2009 06:52:18 Etc/GMT</pubDate></item><item><title>Evotec Announces Research Agreement With Biogen Idec (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090909/172902.html?.v=1</link><description>HAMBURG, Germany and OXFORD, UK -- Evotec AG , a leading provider in the discovery and development of novel small molecule drugs, today announced that it has entered into a research agreement with Biogen Idec , a leading biopharmaceutical company headquartered in Cambridge, Mass., USA.</description><guid isPermaLink="false">yahoo_finance/1288975542</guid><pubDate>Wed, 9 Sep 2009 07:00:00 Etc/GMT</pubDate></item><item><title>Evotec Starts Phase I With EVT 103, An NR2B-Selective NMDA Receptor Antagonist (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090908/172782.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2956863055</guid><pubDate>Tue, 8 Sep 2009 06:10:10 Etc/GMT</pubDate></item><item><title>Evotec Completes Acquisition of Controlling Majority Stake in Research Support International Private Limited (RSIPL) (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090831/172306.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1593171928</guid><pubDate>Mon, 31 Aug 2009 13:20:24 Etc/GMT</pubDate></item><item><title>Evotec Announces Strong Second Quarter Financial Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090807/170969.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4014722464</guid><pubDate>Fri, 7 Aug 2009 05:39:12 Etc/GMT</pubDate></item><item><title>Evotec Accelerates Growth Strategy of its Discovery Alliance Business with Acquisition of Indian RSIPL (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090806/170844.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2273107929</guid><pubDate>Thu, 6 Aug 2009 10:30:44 Etc/GMT</pubDate></item><item><title>Evotec to Report First Half 2009 Results On August 7, 2009 (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090730/170260.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1594944117</guid><pubDate>Thu, 30 Jul 2009 12:19:16 Etc/GMT</pubDate></item><item><title>Evotec Receives Milestone Payment From Boehringer Ingelheim (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090729/170092.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2587479030</guid><pubDate>Wed, 29 Jul 2009 07:20:29 Etc/GMT</pubDate></item><item><title>Evotec Announces Research Agreement On Fragment Based Screening Drug Discovery With Cubist Pharmaceuticals (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090714/168906.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1822930933</guid><pubDate>Tue, 14 Jul 2009 07:06:14 Etc/GMT</pubDate></item><item><title>Evotec Announces the Successful Completion of the First Phase I Study With EVT 401, An Oral P2X7 Receptor Antagonist -- Very Good Safety Profile and Confirmed &apos;On Target Activity&apos; (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090629/168002.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/418344303</guid><pubDate>Mon, 29 Jun 2009 06:03:57 Etc/GMT</pubDate></item><item><title>Evotec Announces First Quarter Results and Corporate Development Update (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090512/165213.html?.v=4</link><description></description><guid isPermaLink="false">yahoo_finance/500931266</guid><pubDate>Tue, 12 May 2009 05:31:10 Etc/GMT</pubDate></item></channel></rss><!-- c4.finance.sp2.yahoo.com compressed/chunked Tue Jan  5 19:37:05 PST 2010 -->
